Post Marketing Surveillance of Nintedanib in Indian Patients With Non-small Cell Lung Cancer (NSCLC) After First-line Therapy

NCT03017885 · clinicaltrials.gov ↗
COMPLETED
Status
28
Enrollment
INDUSTRY
Sponsor class

Conditions

Sponsor

Boehringer Ingelheim